CAIRO Journal Club shared a post on LinkedIn:
“ADC Academy, a new learning platform dedicated to Antibody-Drug Conjugates (ADCs), was developed through a unique collaboration between Cairo Journal Club and AstraZeneca.
Whether you’re a physician, pharmacist, or researcher, ADC Academy is your gateway to staying ahead in the rapidly advancing world of targeted cancer therapeutics.”
Loay Kassem, Assistant Professor of Clinical Oncology at Kasr AlAiny School of Medicine, shared this post, adding:
“Don’t miss this great meeting with top notch experts in the field.
You need to register to the ADC Academy platform to start this educational journey in the hottest topic in modern oncology. “
More posts featuring ADC Academy.